{"disease":{"id":"primary-immunodeficiencies","name":"primary immunodeficiencies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01953016","title":"Participation in a Research Registry for Immune Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":716,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT07251179","title":"Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT06659588","title":"Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04636502","title":"Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Outcome of CUVITRU and HYQVIA in Pediatric Participants (< 18 Years) With Primary Immunodeficiency (PID)","phase":"","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Shire","has_results":false},{"nct_id":"NCT06954441","title":"V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}